Invention Grant
US07772240B2 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
有权
反式-1（6-氯-3-苯基茚-1-基）-3,3-二甲基哌嗪
- Patent Title: Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
- Patent Title (中): 反式-1（6-氯-3-苯基茚-1-基）-3,3-二甲基哌嗪
-
Application No.: US10568292Application Date: 2004-08-18
-
Publication No.: US07772240B2Publication Date: 2010-08-10
- Inventor: Benny Bang-Andersen , Klaus Peter Bogeso , Henrik Svane , Lars Ole Lyngso , Allan Carsten Dahl , Mark Howells , Klaus Gjervig Jensen , Tomas Mow
- Applicant: Benny Bang-Andersen , Klaus Peter Bogeso , Henrik Svane , Lars Ole Lyngso , Allan Carsten Dahl , Mark Howells , Klaus Gjervig Jensen , Tomas Mow
- Applicant Address: DK Valby-Copenhagen
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby-Copenhagen
- Agent Stephen G. Kalinchak; Margaret M. Buck
- Priority: DK200301180 20030818; DK200301305 20030911
- International Application: PCT/DK2004/000546 WO 20040818
- International Announcement: WO2005/016901 WO 20050224
- Main IPC: A61K31/495
- IPC: A61K31/495 ; C07D241/04
Abstract:
A compound 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-2,2-dimethylpiperazine and salts thereof, pharmaceutical compositions comprising the compound and salts, and medical use thereof, including for treatment of schizophrenia and other psychotic disorders.
Public/Granted literature
- US20060281758A1 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine Public/Granted day:2006-12-14
Information query
